(Q38965039)
Statements
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial (English)
Joshua T Kantrowitz
Scott W Woods
Barbara Cornblatt
Huaihou Chen
Gail Silipo
Daniel C Javitt
28 April 2015